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Abstract: Being a non-invasive and relatively safe technique, photothermal therapy has attracted 
a lot of interest in the cancer treatment field. Recently, nanostructure technology has entered 
the forefront of cancer therapy owing to its ability to absorb near-infrared radiation as well as 
efficient light to heat conversion. In this study, key nanostructures for cancer therapy including 
gold nanoparticles, magnetite iron oxide nanoparticles, organic nanomaterials, and novel two-
dimensional nanoagents such as MXenes are discussed. Furthermore, we briefly discuss the 
characteristics of the nanostructures of these photothermal nanomaterial agents, while focusing on 
how nanostructures hold potential as cancer therapies. Finally, this review offers promising insight 
into new cancer therapy approaches, particularly in vivo and in vitro cancer treatments.
Keywords: photothermal therapy, nanostructures, near-infrared, plasmonic, cancer therapy
Introduction
Globally, cancer as an invasive and malignant disease is considered the second leading 
cause of mortality. As per the American Cancer Society, the estimated number of cancer 
incidence in 2017 is 1,688,780 new cancer cases and 600,920 cancer deaths in USA, which 
implies a potential increase of 70% over the next 2 decades.1,2 Current cancer therapies, 
such as surgical excision, chemotherapy, radiation therapy, or even combination therapy, 
have severe limitations. Surgery could result in hurt or injury in the adjacent healthy 
critical tissues, and both chemotherapy and radiotherapy exhibit violent side effects.3
Recently, photothermal therapy (PTT) has gained a great deal of attention due to 
its excellent performance in cancer treatment. PTT depends on heat generation upon 
exposure of tumor cells to near-infrared radiation (NIR).4–6 PTT agents absorb light 
energy, which causes electron excitation and subsequent non-radiative relaxation. This 
will lead to gain kinetic energy, which in turn results in heat generation in the medium 
surrounding the PTT agents.7–9 This PTT approach is considered as non-invasive ther-
motherapy in which the induced thermal energy develops cell membrane disruption 
or protein denaturation of the surrounding tumor cells.10
Coupled with that, a major breakthrough in nanotechnology has been developed 
resulting in the production of various nanomaterials for many applications. Due to their 
unique optical properties, nano-scaled materials, especially noble metal nanoparticles 
(NPs), are promising in the nanomedicine and biomedical fields.11–14 The noble metal 
NPs such as gold (Au) and silver (Ag) have a unique photo-physical phenomenon, 
called localized surface plasmon resonance (LSPR), which enhances their photo-
absorption.15–18 Consequently, they are considered as PTT because of their ability to 
stimulate hyperthermia in the cancerous cells, when exposed to NIR.19–21 This phe-
nomenon is due to the special optical properties of noble metal NPs, which are able 
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to absorb the light energy in NIR region (ie, 650–900 nm). 
Then, the absorbed light energy is converted to heat leading 
to tumor cell damage and tumor tissue necrosis.3
To illustrate, the surface plasmon resonance (SRP) 
effect means that the metal-free electrons that exist in the 
conduction band oscillate around the particle surface when 
exposed to the electromagnetic field of light. Subsequently, 
this oscillation leads to charge separation and formation of 
dipole oscillation (Figure 1). At a certain frequency, the 
oscillation will reach its maximum which is known as SPR, 
which supports the light absorption of the NPs, especially 
the noble metals (ie, Au and Ag).22–25
The conversion of the absorbed light to heat proceeds 
through three main photo-physical processes. The first and sec-
ond processes allow for the formation of a hot metallic lattice 
in the metal NPs, and the last one allows for a cooling off, 
which means heat dissipation from the NPs to the surrounding 
environment. Accordingly, the dissipated energy will heat 
up the cancerous cells around the Au nanoparticles (AuNPs) 
causing cell destruction. However, such energy conversion and 
dissipation occur when the frequency of the incident light is 
overlapped with the SPR absorption band.24–27 Figure 2 shows 
the schematic presentation of the three processes included in 
the light to heat conversion mechanism.
On the other hand, exposure of the healthy cells to 
electromagnetic radiation of light raises the concern about 
the safety of this type of therapy. With respect to the LSPR 
frequency, the incident laser light is generally in the visible 
region or in the NIR region. In vivo, the radiation can be 
normally absorbed in the tissue by water, hemoglobin, and 
melanin.3 However, NIR laser light is weakly absorbed by 
these absorbents; hence, it can penetrate the skin without 
causing damage to normal tissues.24,28 Under such cir-
cumstances, many researchers have opened the door for 
the application of several nanomaterials, which strongly 
absorb the NIR and, as a result of SPR effect, gener-
ate sufficient heat to cause tumor cell death.
Functional nanostructures as 
cancer PTT
In this study, we introduce a recent literature review about 
nanomaterials used as a cancer PTT over the past 5 years. 
Different nanostructures developed even from the same 
material or combination of two or three PTT agents were 
reported to enhance the efficiency or to decrease the toxicity. 
For simplicity, this review covers mainly the application 
of diverse nano-scaled materials, either single or hybrid 
nanostructures, but does not cover the implication of any 
therapeutic agent or anticancer drug of the nanomaterials.
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Figure 1 (A) Schematic description of localized surface plasmon resonance in metal 
NPs. (B) Dark-field image of NPs. (C) Scattering spectrum of a single NP.
Notes: Reproduced from Xie T, Jing C, Long YT. Single plasmonic nanoparticles 
as ultrasensi tive sensors. Analyst. 2017;142(3):409–420,25 http://pubs.rsc.org/en/
Content/ArticleLanding/2017/AN/C6AN01852A#!divAbstract, with permission of 
The Royal Society of Chemistry.
Abbreviations: LSPR, localized surface plasmon resonance; NP, nanoparticle.
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Figure 2 Schematic illustration of light to heat conversion by plasmonic nanostructures. 
Notes: Step 1 is excitation of metal nanoparticles by the absorbed light photons, which results in particle oscillation and charge separation. Step 2 is conversion of the 
absorbed light to heat through electron–electron relaxation and electron–phonon relaxation processes, which result in the formation of hot metallic lattice. Step 3 is cooling 
off the metal structure through electron–phonon coupling and phonon–phonon relaxation, which cause heat dissipation. Reproduced from webb JA, Bardhan R. emerging 
advances in nanomedicine with engi neered gold nanostructures. Nanoscale. 2014;6(5):2502,27 http://pubs.rsc.org/en/content/articlelanding/2014/nr/c3nr05112a#!divAbstract, 
with permission of The Royal Society of Chemistry.
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Au-based nanomaterials
One of the most promising PTT nanomaterials for cancer 
treatment is Au nanostructures, as they can be synthesized 
in different forms such as nanorods, nanoshells, nanocages, 
or nanospheres. Beyond their plasmonic effect, they have 
an enhanced permeability to tumor vasculature, resulting in 
higher retention in tumor tissue. Because the tumor vascular 
system possesses gaps ranging in size from 100 nm to 2 µm, 
AuNPs can penetrate easily; these NPs are retained due to lym-
phatic clearance deficiency in the cancerous cells.18 Although 
AuNPs can successfully pass into the tumor tissue, they are 
subjected to phagocytosis by macrophages. Hence, AuNPs 
are sometimes coated with biocompatible polymers to inhibit 
reuptake by phagocytic cells.29 In addition, AuNPs were 
reported as good biocompatible NPs with low cytotoxicity.30 
Nanomaterials are unable to differentiate between cancerous 
cells and normal cells. In some studies, however, AuNPs were 
conjugated with a specific antibody-targeted cancer receptor 
to achieve minimal binding with healthy tissues.31–33
The optical properties of different Au nanostructures are 
greatly affected by altering their shapes and sizes. Research 
studies used these properties to tune the resonance in the 
NIR region according to the desired applications.27 In detail, 
more complex shapes such as Au nanorods (AuNRs), nano-
shells, and nanostars exhibited more enhanced LSPR effect 
than simple AuNPs.34,35 Kelly et al36 demonstrated that 
complex geometrical shapes improved the polarizability of 
Au nanostructures due to additional bumps and protrusions.
To illustrate, polarizability of AuNPs arises from their diam-
eter only, while polarizability of Au-nanostar was enhanced 
by their projections, which increase the overall polarizability 
resulting in red shift in the plasmon resonance wavelength.37 
In addition to shape, increasing the size of Au nanostructures 
enhances the electron oscillation around Au nanostructure 
leading to increasing the oscillation time and decreasing the 
frequency. This phenomenon is called phase retardation, 
which results in prolonged lifetime of plasmon and red shift 
of the resonance wavelength as well.27,38
Findings from recent research support the application of 
Au-based nanomaterials as PTT. Ali et al39 studied the effect 
of AuNRs on human oral squamous cell carcinoma (HSC-3) 
by analyzing the data from Raman spectroscopy, metabolom-
ics, and proteomics mass spectrometry. They claimed that the 
AuNR-treated cancer cells exhibited high levels of phenylala-
nine resulting in cell apoptosis. Similarly, a long-term in vivo 
study was carried out in mouse tumor tissues to discover the 
efficiency of AuNRs as PTT agents.40 The authors compared 
the apoptotic effect induced by gold nanorods conjugated to 
rifampicin (AuNRs@RF) to the apoptotic effect induced by 
gold nanorods conjugated to polyethelyne glycole (AuNRs@
PEG). By using proteomics analysis, it was found that AuNRs@
RF has more efficient endocytosis and easier cellular uptake 
resulting in increased neutrophil cell death (NETosis).
Moreover, AuNRs were found to minimize metastasis 
via inhibition of cancer cell migration.41 This occurs because 
AuNR surface, when conjugated to specific peptides, induces 
changes in migration-related proteins (integrins), which 
result in controlling cancer metastasis. Another key point is 
the effect of Au nanomaterial concentration on NIR-induced 
hyperthermia. Singh et al42 investigated the optimal concen-
tration of AuNRs to be an efficient PTT in vitro using human 
esophagogastric tissues. They studied different concentra-
tions of AuNRs and variable power densities. Their results 
showed a linear relationship between temperature elevation 
and laser power and AuNR concentration.
During treatment with a PTT agent, excessive reactive 
oxygen species (ROS) could be produced as a result of heat 
shock.43–45 Thus, ROS can cause protein damage leading to 
cell death. Sometimes, ROS levels increased in degenerative 
diseases such as Alzheimer or even in progressive disease 
such as cancer.46–49 Interestingly, platinum-coated Au nano-
rods were proved to be used in cancer therapy as a PTT with 
simultaneous ROS scavenging.50 Platinum shells of varying 
thickness were examined and showed no interference with 
the photothermal effect of AuNRs, as well as no impairment 
of the thermal response to NIR laser waves.
In addition, a new strategy was reported by Wu et al51 
to synthesize nanotubes of Au-attapulgite composite, where 
attapulgite is a natural and biocompatible clay. The nano-
composite was prepared by the assembly of AuNPs on the 
surface of attapulgite. The authors stated that the synthe-
sized tube-like nanocomposite could act as an efficient PTT 
when tested using A549 cells (human adenocarcinoma cell). 
Furthermore, a new Au nanostructure (Au nanobipyramids) 
was reported to be applied for breast cancer detection and 
treatment in which Au nano-bipyramids were bio-conjugated 
with 2-naphthalenethiol and folic acid to target and kill 
human breast (adenocarcinoma) cells.52 The authors revealed 
that the conjugated Au nano-bipyramids are capable of quan-
titative detection of the MCF-7 cells as well as enhancement 
of photothermal effect in vivo and in vitro.
On the contrary, there are some challenges in the clini-
cal application of Au nanostructures as PTT agents. For 
instance, lack of stability inside the body and agglomeration 
of Au nanostructures is the most challenging factor upon in 
vivo application.27 Some modifications, such as attaching a 
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surface ligand and dispersion in phosphate buffer with suit-
able pH, could be carried out during synthesis to increase the 
in vivo stability and decrease the aggregation, respectively.53 
However, the use of natural surface ligands results in lower 
yield from Au nanostructures,54 and the use of high salt or 
basic buffer can cause surface instability and aggregation of 
the nanostructures.55
Iron oxide (Fe3O4) NPs
Due to unique magnetism, non-toxicity, biodegradability, 
and biocompatibility, magnetite Fe
3
O
4
 NPs have been widely 
reported in biomedical applications.56–61 For instance, Fe
3
O
4
 
NPs were extensively used in drug delivery systems, cell tar-
geting, and in magnetic resonance imaging (MRI) as contrast 
agents. In addition, they possess a unique surface, which is 
able to carry targeting molecules for cancer cells and go deeply 
into tumor tissues.62 Furthermore, Fe
3
O
4
 NPs have been proved 
useful for cancer treatment due to their magnetic hyperthermia 
in which induced high temperatures were achieved and con-
trolled by alternating magnetic field (AFM).63 The generated 
heat is sufficient to destroy cancerous cells but may affect 
healthy tissues. For this reason, the use of NIR laser radiation 
(widely used in therapy and diagnosis) to induce hyperthermia 
has an added safety advantage compared to AFM.64
Fe
3
O
4
 nanomaterials of different shapes (ie, spherical, 
hexagonal, and wire-like particles) were investigated for 
photothermal effect on human esophageal cancer cells 
(Eca-109). It was found that NIR-induced hyperthermia by 
spherical Fe
3
O
4
 NPs exhibited significant cytotoxicity and 
suppression of tumor growth.64 Shen et al65 have synthesized 
both individual and clustered Fe
3
O
4
 NPs and investigated 
their thermo-therapeutic effect in vivo and in vitro. They 
used human lung adenocarcinoma epithelial (A549) cells for 
in vitro testing and flow cytometry analysis to investigate the 
cell apoptosis effect. The clustered Fe
3
O
4
 NPs were shown 
to have higher NIR-induced hyperthermia and increased cell 
death compared to individual one.
The effect of coating Fe
3
O
4
 NPs with an anti-biofouling 
polymer was studied and compared to commercial magnetic 
NPs (FeREX, BioPAL) for their anticancer activity.66 The 
study showed that highly crystallized iron oxide nanoparticles 
(HCIONPs) offered more potential photothermal effect in vivo 
and in vitro due to their preferred lattice orientations. Conse-
quently, this approach was suggested for clinical use in cancer 
treatment. Furthermore, Zhou et al67 developed iron/iron oxide 
core–shell nanoparticles (Fe@Fe
3
O
4
 NPs) that have advantages 
of NIR photothermal therapeutic effect, selective magnetic 
targeting, and MRI for complete tumor treatment. Another 
study investigated the efficiency of FePt NPs functionalized 
with folates to target breast cancer cells EMT-6.68 The findings 
revealed that the FePt NP exhibited intracellular explosions 
accompanied by rupture of cancerous cell membranes.
The main limitation of most studies is the use of highly 
intense laser irradiation, which might exceed the safe limit 
for cutaneous tissues (0.33 W/cm2). However, Espinosa 
et al69 mitigated this drawback and reported the dual magnetic 
and photothermal activity of Fe
3
O
4
 nanocubes. The authors 
applied a magnetic field in alternating patterns and NIR laser 
of reasonable irradiation density (0.3 W/cm2). Such dual 
approach showed complete cell death and tumor ablation 
even at low iron doses.
Organic nanomaterials
Owing to their enhanced biocompatibility and low toxicity, 
organic nanomaterials have recently been reported for a wide 
variety of biomedical applications.70 In particular, they can be 
used as PTT agents because they exhibit an efficient light-to-
heat conversion. Moreover, organic materials have a strong 
NIR absorption resulting from their diffused bi-electrons.71 
Therefore, reduced graphene oxide (rGO) nanosheets as an 
example have a high extension coefficient (3.6 L g−1cm−1).72 
Carbon-based nanomaterials (ie, carbon nanotubes and 
graphene), organic dyes, and polymer nanocarriers are the most 
widely reported organic-based photothermal nanoagents.
Liang et al73 have synthesized PEGylated single-walled 
carbon nanotubes (SWCNTs) and demonstrated their effi-
ciency as a PTT. They investigated the therapeutic effect of 
PEGylated SWCNTs on metastasis of primary 4T1 murine 
breast tumor to lymph node. The findings showed the ability 
of PEGylated SWCNTs to suppress the primary tumor and the 
pulmonary metastasis. Similarly, a novel SWCNT-peptide 
composite showed an effective photothermal effect on colon 
26 and HepG2 cells after 3 minutes of NIR radiation.74
Graphene, as a carbon-based nanomaterial, has bio-
medical applications such as biosensors, drug carriers, and 
a very recent application as a PTT due to its strong NIR 
absorption.75–77 However, graphene is still considered to 
exhibit some biological toxicity because of poor dispersibility 
in physiological fluids. Consequently, most of the graphene-
based PTT agents were modified with surface functionaliza-
tion to mitigate the bio-toxicity limitation.77–79 To figure out 
photothermal efficiency of graphene and graphene oxide 
(GO), their ability to produce heat after laser irradiation was 
investigated and compared to AuNRs using an integrating 
sphere method and the time constant method.80
Graphene or GO as two-dimensional (2D) nanosheets 
with large surface area can be mixed with certain functional 
NPs for diagnostic and therapeutic purposes.81 For example, 
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BaGdF
5
 NPs attached to the PEG-coated GO surface were fab-
ricated by Zhang et al82 for both MRI and photothermal cancer 
therapy. The synthesized nanocomposites were injected into 
mice bearing HeLa tumor and irradiated for 10 minutes with 
808 nm laser (power density of 0.5 W/cm2). When the tumor 
tissue samples were collected for histological examination, 
the results showed that the treated group acquired thermone-
crosis and cell shrinkage. Chen et al83 developed radiolabeled 
reduced GO coated with PEG (131I-rGO-PEG) for combined 
radiotherapy and PTT. The results showed high synergistic 
effect on 4T1 murine breast cancer therapy due to the combi-
nation between radioactive 131I and strong NIR absorption of 
PEG-coated rGO as well as no apparent animal toxicity.
The literature revealed many articles concerned with the 
use of organic dyes such as cyanine and porphyrin derivatives 
as efficient photothermal agents. The most common cyanine 
derivative indocyanine green (ICG) dye, which was approved 
by the US Food and Drug Administration for clinical use, 
was reported in combination with nanocarriers as a PTT with 
a good efficiency in vitro and in vivo for tumor ablation.84–86 
The nanocarriers containing ICG dye showed enhanced 
aqueous stability and better cellular uptake compared to 
the direct dyes. However, most of these studies have poor 
photostability at high-power laser irradiation, which means 
limited use to preclinical studies.70 Similarly, porphyrin-
based nanomaterials showed its activity as PTT for the treat-
ment of different tumors as well as their biodegradability and 
biocompatibility.87 However, it is important to mention that 
porphyrin nanoagents exhibit short absorption wavelength 
(600–700 nm), which restricts their in vivo application.70
In the last decade, NPs of conductive polymers have been 
reported for biomedical applications due to their high stability 
and biocompatibility. In particular, polypyrrole (PPy) and 
poly-(3,4-ethylenedioxythiophene):poly(4-styrenesulfonate) 
(PEDOT:PSS) have strong NIR absorbance, making them 
suitable as photothermal agents for cancer therapy. Both PPy 
and PEDOT:PSS were examined for tumor ablation in vivo 
and in vitro, showing high efficiency without undesired 
effects.88–91 However, the clinical use of polymer NPs is still 
limited due to lack of safety data.70
Combined nanomaterials
In general, the combination between two PTT agents to 
synthesize nanocomposites or core–shell NPs provides 
novel physical and chemical properties.92 In addition, these 
nanocomposites act as multi-function nanomaterials with 
tunable size and composition. The optical properties were 
enhanced while using two or more nanostructures to synthe-
size a hybrid PTT.93 Therefore, strong plasmonic effect and 
surface-enhanced Raman scattering were reported for many 
combined PTT.
Hybrid NPs consisting of Au and Fe
3
O
4
 were synthesized 
to get new and unique physical and chemical properties. The 
plasmonic effect was investigated by using optical absorption 
measurements such as UV-vis92 and surface-enhanced Raman 
spectra.93 Owing to their potential application as PTT, the 
optical properties of Fe
3
O
4
@Au core–shell were simulated by 
using the extended Mie theory.94–96 Investigations of absorp-
tion cross-section spectra as well as the relationship between 
the resonance wavelength and the elevated temperature were 
conducted.97 In addition, Ahmed et al98 studied the in vitro 
cell viability of Fe
3
O
4
@AuNPs by using the MTT assay. 
They found 50 µg/mL of Fe
3
O
4
@AuNPs to be non-toxic 
and biocompatible.
Another example of hybrid therapy is the combination 
between ICG organic dye and Fe
3
O
4
 NPs investigated by Niu 
et al.99 The authors used the two synergistic PTT agents encap-
sulated in perfluoropentane-based polylactide-co-glycolide 
(Fe
3
O
4
/ICG@PLGA/PFP NPs) and evaluated their efficiency 
toward tumor ablation. When Fe
3
O
4
/ICG@PLGA/PFP NPs 
were incubated with MCF-7 human breast cancer cells and 
irradiated with 808 nm laser for 5 minutes, they showed 
tissue deformation and significant cell death. Furthermore, 
effectiveness of this dual NIR therapy was assessed in vivo 
by using mice bearing MCF-7 cells. The results revealed 
reduced tumor size and inhibition of tumor growth with no 
significant toxicity in vital organs such as liver, kidney, heart, 
spleen, and brain.
Meng et al100 developed golden SWCNT hybrids with 
enhanced NIR absorption, excellent water dispersibility, and 
better biocompatibility. The novel hybrids were synthesized 
by layer-by-layer self-assembly of two different polysaccha-
rides on the SWCNT skeleton, followed by growing AuNPs 
on the surface. Highly effective photothermal activity was 
achieved, when the golden SWCNTs were incubated over-
night with HeLa cells and irradiated for 15 minutes with 
808 nm laser diode.
In addition, graphene-based hybrid PTT has been recently 
reported to have the advantages of carbon-based materi-
als and metal NPs. For example, combination of GO with 
AuNPs revealed an enhanced tumor ablation in vivo and 
in vitro at lower laser irradiation (0.75 W/cm2).101 Similarly, 
reduced GO/AuPd NPs/PEG-coated nanocomposites were 
evaluated for the suppression of HeLa cells in vitro showing 
good results after laser irradiation for 10 minutes.102 For the 
purpose of improving light-to-heat conversion as well as 
targeting the tumor tissues, combined GO/magnetic iron NP 
hybrids were also reported in the literature.81,103 However, 
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laser-induced hyperthermia in these articles were substituted 
by magnetic hyperthermia, which is induced by AFM to 
mitigate the limited penetration of NIR into the tissues.104
Nanocomposites of AuNRs coated with pyrrole con-
ductive polymer have gained a great interest due to high 
photostability and biocompatibility in addition to improved 
photothermal activity.105 Likewise, Au/pyrrole NPs with 
Fe
3
O
4
 NPs deposited on the surface were synthesized by Feng 
et al106 for cancer therapy. The Au/pyrrole@Fe
3
O
4
 nanocom-
posites were considered to be multifunctional nanoagents 
with enhanced photothermal conversion, superparamagnetic 
properties, and good biocompatibility.
Novel 2D materials
New family of 2D nanosheets have been recently reported in 
the literature for many biomedical applications. Owing to high 
biocompatibility, excellent physicochemical performance as 
well as unique photothermal conversion efficiency, various 
2D nanostructures are considered to be promising PTT agents 
for cancer therapy.107 MXenes are recently reported but widely 
spread new 2D materials, having a general formula of M
n+1Xn, 
where M represents a transition metal and X represents carbon 
or nitrogen.108,109 One of the most powerful 2D PTT nano-
agents is Ti
3
C
2
 (MXene), which shows strong NIR absorp-
tion and high light-to-heat conversion property. To explain, 
the exfoliated ultrathin MXene nanosheets demonstrate 
semimetal-like band energy structure; consequently, they have 
the LSPR effect similar to metal NPs.110 The same condition 
is applied for the transition of metal dichalcogenides such 
as tungsten sulfide (WS
2
), molybdenum sulfide (MoS
2
), and 
titanium sulfide (TiS
2
) as well as black phosphorus.111,112
Lin et al110 synthesized phospholipid-stabilized ultrathin 
Ti
3
C
2
 nanosheets (MXene) by prolonged etching of Ti
3
AlC
2
 
using hydrofluoric acid (HF), followed by intercalation with 
tetrapropylammonium hydroxide (TPAOH) and surface mod-
ification with soybean phospholipids (SP). They evaluated 
the cytotoxicity of Ti
3
C
2
-SP nanoflakes and the tumor abla-
tion ability in vivo and in vitro by using 4T1 tumor-bearing 
mice and murine 4T1 breast cancer cells, respectively. The 
results showed that the groups treated with the stabilized 
MXenes revealed high percentage of 4T1 cancer cell death 
in vitro and significant decrease of tumor size in vivo after 
exposure to NIR laser irradiation for few minutes. Similarly, 
by using the same mouse model, MXene-based hybrids such 
as MnO
x
-Ti
3
C
2
 composites were prepared and investigated 
for tumor ablation and MRI by Dai et al.113
Table 1 summarizes different nano-scaled PTT agents 
applied for different types of cancer cells. From Table 1, it is 
clearly observed that the combination between two or more 
PTT agents contributed in reducing the power densities of 
Table 1 Summary of different nanomaterials reported as PTT agents applied on various types of tumor cells
PTT nanoagent Cancer cell type Photothermal conditions References
Au-based nanomaterials
AuNRs Human oral squamous cell carcinoma (HSC-3) 808 nm NIR laser irradiation 
(5.8 w/cm2) for 3 min
41
Au-attapulgite composite Human lung adenocarcinoma cells (A549) 808 nm laser (0.5 w/cm2) for 15 min 51
AuNBPs Human breast cancer cells (MCF-7) 808 nm laser (2 w/cm2) for 5 min 52
Magnetic Fe3O4 nanomaterials
Fe3O4 NPs A549 cells 808 NIR (5 w/cm
2) for 1–3 min 65
Fe3O4 nanocubes Three malignant cell lines (SKOv3, PC3, and A431) Dual magneto-photothermal
(alternating magnetic field and NIR 
laser [0.3 w/cm2 for 5 min])
69
Organic nanomaterials
SwCNT composite The murine rectum carcinoma cell line (colon 26) and 
human hepatocellular carcinoma cell line (HepG2)
808 nm NIR laser (1.2 w/cm2) 
for 3 min
74
GO-BaGdF5 nanocomposites Mice bearing HeLa tumor cells 808 nm laser (0.5 w/cm
2) for 10 min 82
Polypyrrole hollow microspheres Human umbilical vein endothelial cells (HUveCs) 808 nm laser (6 w/cm2) for 5 min 90
Combination therapy
Fe3O4/ICG@PLGA/PFP NPs MCF-7 808 nm laser for 5 min 99
GO/AuNPs Squamous cell carcinoma (SSC7) 808 nm laser (0.3 w/cm2) for 10 min 101
AuPd NPs–rGO nanocomposites HeLa cells 808 nm laser (1 w/cm2) for 10 min 102
Novel 2D materials
Ti3C2 nanosheets (MXenes) Murine 4T1 breast cancer cells 808 nm laser (1 w/cm
2) for 5 min 110
Others
Antimony NPs 4T1 cells 808 nm laser (2 w/cm2) for 5 min 114
Iron carbide (Fe5C2) NPs Human ovarian cancer cell line (SK-Ov-3) 808 nm laser (0.8 w/cm
2) for 5 min 115
Tungsten oxide nanorods HeLa cells 980 nm laser (0.35 w/cm2) for 8 min 116
Abbreviations: AuNRs, gold nanorods; AuNBPs, gold nanobipyramids; GO, graphene oxide; NIR, near-infrared; NP, nanoparticle; PTT, photothermal therapy; SwCNT, 
single-walled carbon nanotube.
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laser irradiation near to the safety limit in addition to decreas-
ing the exposure radiation time.
Conclusion and future perspective
Throughout this review, new insights for cancer treatment 
have been addressed, focusing on the promising benefits 
of employing the PTT types. It is evident from ineffective 
conventional treatments that there is a desperate necessity 
for distinct and unique treatments. As extensively explained, 
nanostructure technology has the potential to play critical 
functions in cancer therapy, through directly acting as PTT. 
Of note, nanostructures with various shapes were revealed 
as PTT due to their strong NIR absorption and efficient 
light-to-heat conversion. Investigation through various 
nanostructure studies revealed that the mentioned concepts 
attempt to strengthen their overall photothermal therapeutic 
behavior. As represented by numerous reports, therapies 
including AuNPs, Fe
3
O
4
 NPs, organic nanomaterials, and 
novel 2D nanoagents have the potential to directly enhance 
the in vivo and in vitro cancer therapies. In addition, hybrid 
nanomaterials with two or more PTT agents have superior 
advantages of synergism, which leads to enhanced efficiency 
and reduced toxicological effects of every single therapy. 
To sum up, nanostructures are considered promising candi-
dates for tumor ablation as PTT agents due to their unique 
optical properties. However, in vivo stability and more 
detailed toxicity studies should be covered in the future for 
the PTT nanoagents to be clinically approved.
Acknowledgments
The authors gratefully acknowledge Qatar University for 
Graduate Assistantship and they would also like to show 
gratitude to Dr Mary Newsome (Office of Graduate Studies, 
Qatar University) for discussions and useful suggestions of 
writing this paper. The authors would also like to acknowl-
edge Qatar University for funding the project: GCC Co-Fund 
Program Grant GCC-2017-001. 
Disclosure
The authors report no conflicts of interest in this work.
References
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 
2017;67(1):7–30.
2. Cancer Fact Sheet. World Health Organization; 2017. Available from: 
http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed December 
12, 2017.
3. Day ES, Morton JG, West JL. Nanoparticles for thermal cancer therapy. 
J Biomech Eng. 2009;131(7):74001.
4. Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared 
light-activatable multimodal nanoparticles. Acc Chem Res. 2011;44(10): 
947–956.
 5. Kennedy LC, Bickford LR, Lewinski NA, et al. A new era for cancer 
treatment: Gold-nanoparticle-mediated thermal therapies. Small. 
2011;7(2):169–183.
 6. Yang K, Feng L, Shi X, Liu Z. Nano-graphene in biomedicine: thera-
nostic applications. Chem Soc Rev. 2013;42(2):530–547.
 7. Camerin M, Rello S, Villanueva A, et al. Photothermal sensitisation 
as a novel therapeutic approach for tumours: studies at the cellular and 
animal level. Eur J Cancer. 2005;41(8):1203–1212.
 8. Camerin M, Rodgers MAJ, Kenney ME, Jori G. Photothermal sensiti-
zation: evidence for the lack of oxygen effect on the photosensitizing 
activity. Photochem Photobiol Sci. 2005;4(3):251–253.
 9. He X, Bischof JC. Quantification of temperature and injury response in 
thermal therapy and cryosurgery. Crit Rev Biomed Eng. 2003;31(5–6): 
355–422.
 10. van der Zee J. Heating the patient: a promising approach? Ann Oncol. 
2002;13(8):1173–1184.
 11. El-Sayed MA. Some interesting properties of metals confined in time and 
nanometer space of different shapes. Acc Chem Res. 2001;34(4):257–264.
 12. Niemeyer CM. Nanoparticles, proteins, and nucleic acids: biotechnology 
meets materials science. Angew Chem. 2001;40(22):4128–4158.
 13. West JL, Halas NJ. Engineered nanomaterials for biophotonics applica-
tions: improving sensing, imaging, and therapeutics. Annu Rev Biomed 
Eng. 2003;5(1):285–292.
 14. Katz E, Willner I. Integrated nanoparticle-biomolecule hybrid 
systems: synthesis, properties, and applications. Angew Chem. 
2004;43(45):6042–6108.
 15. Dreaden EC, Alkilany AM, Huang X, Murphy CJ, El-Sayed MA. The 
golden age: gold nanoparticles for biomedicine. Chem Soc Rev. 2012; 
41(7):2740–2779.
 16. Dreaden EC, Mackey MA, Huang X, Kang B, El-Sayed MA. Beating can-
cer in multiple ways using nanogold. Chem Soc Rev. 2011;40(7):3391.
 17. Huang X, Neretina S, El-Sayed MA. Gold nanorods: from synthesis 
and properties to biological and biomedical applications. Adv Mater. 
2009;21(48):4880–4910.
 18. Lee J, Chatterjee DK, Lee MH, Krishnan S. Gold nanoparticles in breast 
cancer treatment: promise and potential pitfalls. Cancer Lett. 2014; 
347(1):46–53.
 19. Jain PK, Huang X, El-Sayed IH, El-Sayed MA. Noble metals on the 
nanoscale: optical and photothermal properties and some applications in 
imaging, sensing, biology, and medicine. Acc Chem Res. 2008;41(12): 
1578–1586.
 20. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: 
interesting optical properties and recent applications in cancer diagnos-
tics and therapy. Nanomedicine. 2007;2(5):681–693.
 21. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal 
therapy (PPTT) using gold nanoparticles. Lasers Med Sci. 2008;23(3): 
217–228.
 22. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption 
and scattering properties of gold nanoparticles of different size, shape, 
and composition: applications in biological imaging and biomedicine. 
J Phys Chem B. 2006;110(14):7238–7248.
 23. Huang X, El-Sayed MA. Gold nanoparticles: optical properties and 
implementations in cancer diagnosis and photothermal therapy. J Adv 
Res. 2010;1(1):13–28.
 24. Huang X, El-Sayed MA. Plasmonic photo-thermal therapy (PPTT). 
Alexandria J Med. 2011;47(1):1–9.
 25. Xie T, Jing C, Long YT. Single plasmonic nanoparticles as ultrasensi-
tive sensors. Analyst. 2017;142(3):409–420.
 26. Link S, El-Sayed MA. Optical properties and ultrafast dynamics of 
metallic nanocrystals. Annu Rev Phys Chem. 2003;54(1):331–366.
 27. Webb JA, Bardhan R. Emerging advances in nanomedicine with engi-
neered gold nanostructures. Nanoscale. 2014;6(5):2502.
 28. Kim J, Park S, Lee JE, et al. Designed fabrication of multifunctional 
magnetic gold nanoshells and their application to magnetic resonance 
imaging and photothermal therapy. Angew Chem. 2006;118(46): 
7918–7922.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
86
.3
6.
66
.1
29
 o
n 
18
-M
ay
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2018:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2904
Hussein et al
 29. Kah JCY, Wong KY, Neoh KG, et al. Critical parameters in the 
pegylation of gold nanoshells for biomedical applications: an in vitro 
macrophage study. J Drug Target. 2009;17(3):181–193.
 30. Hu M, Chen J, Li Z-Y, et al. Gold nanostructures: engineering their 
plasmonic properties for biomedical applications. Chem Soc Rev. 2006; 
35(11):1084–1094.
 31. Lowery AR, Gobin AM, Day ES, Halas NJ, West JL. Immunonanoshells 
for targeted photothermal ablation of tumor cells. Int J Nanomedicine. 
2006;1(2):149–154.
 32. Wu P-C, Shieh D-B, Cheng F-Y. Nanomaterial-mediated photothermal 
cancer treatment: the pivotal role of cellular uptake on photothermal 
therapeutic efficacy. RSC Adv. 2014;4(95):53297–53306.
 33. Loo C, Lowery A, Halas N, West J, Drezek R. Immunotargeted nano-
shells for integrated cancer imaging and therapy. Nano Lett. 2005; 
5(4):709–711.
 34. Yuan H, Khoury CG, Wilson CM, Grant GA, Bennett AJ, Vo-Dinh T. 
In vivo particle tracking and photothermal ablation using plasmon-
resonant gold nanostars. Nanomedicine. 2012;8(8):1355–1363.
 35. Ye X, Gao Y, Chen J, Relfsnyder DC, Zheng C, Murray CB. Seeded 
growth of monodisperse gold nanorods using bromide-free surfactant 
mixtures. Nano Lett. 2013;13(5):2163–2171.
 36. Kelly KL, Coronado E, Zhao LL, Schatz GC. The optical properties of 
metal nanoparticles: the influence of size, shape, and dielectric environ-
ment. J Phys Chem B. 2003;107(3):668–677.
 37. Burda C, Chen X, Narayanan R, El-Sayed MA. Chemistry and properties of 
nanocrystals of different shapes. Chem Rev. 2005;105(4):1025–1102.
 38. Ringe E, Langille MR, Sohn K, et al. Plasmon length: a universal 
parameter to describe size effects in gold nanoparticles. J Phys Chem 
Lett. 2012;3(11):1479–1483.
 39. Ali MRK, Wu Y, Han T, et al. Simultaneous time-dependent surface-
enhanced Raman spectroscopy, metabolomics, and proteomics reveal 
cancer cell death mechanisms associated with gold nanorod photother-
mal therapy. J Am Chem Soc. 2016;138(47):15434–15442.
 40. Ali MRK, Rahman MA, Wu Y, et al. Efficacy, long-term toxicity, and mech-
anistic studies of gold nanorods photothermal therapy of cancer in xeno-
graft mice. Proc Natl Acad Sci U S A. 2017;114(15):E3110–E3118.
 41. Ali MRK, Wu Y, Tang Y, et al. Targeting cancer cell integrins using 
gold nanorods in photothermal therapy inhibits migration through 
affecting cytoskeletal proteins. Proc Natl Acad Sci U S A. 2017;114(28): 
E5655–E5663.
 42. Singh M, Harris-Birtill DCC, Zhou Y, et al. Application of gold 
nanorods for photothermal therapy in ex vivo human oesophagogastric 
adenocarcinoma. J Biomed Nanotechnol. 2016;12(3):481–490.
 43. Slimen IB, Najar T, Ghram A, Dabbebi H, Ben Mrad M, Abdrabbah M. 
Reactive oxygen species, heat stress and oxidative-induced mitochon-
drial damage. A review. Int J Hyperth. 2014;30(7):513–523.
 44. Fedyaeva AV, Stepanov AV, Lyubushkina IV, Pobezhimova TP, 
Rikhvanov EG. Heat shock induces production of reactive oxygen 
species and increases inner mitochondrial membrane potential in winter 
wheat cells. Biochem. 2014;79(11):1202–1210.
 45. Gao L, Liu R, Gao F, Wang Y, Jiang X, Gao X. Plasmon-mediated gen-
eration of reactive oxygen species from near-infrared light excited gold 
nanocages for photodynamic therapy in vitro. ACS Nano. 2014;8(7): 
7260–7271.
 46. Benz CC, Yau C. Ageing, oxidative stress and cancer: paradigms in 
parallax. Nat Rev Cancer. 2009;8(11):875–879.
 47. Uttara B, Singh A, Zamboni P, Mahajan R. Oxidative stress and neuro-
degenerative diseases: a review of upstream and downstream antioxidant 
therapeutic options. Curr Neuropharmacol. 2009;7(1):65–74.
 48. Schieber M, Chandel NS. ROS function in redox signaling and oxidative 
stress. Curr Biol. 2014;24(10):R453–R462.
 49. Cervellati F, Cervellati C, Romani A, et al. Hypoxia induces cell 
damage via oxidative stress in retinal epithelial cells. Free Radic Res. 
2014;48(3):303–312.
 50. Aioub M, Panikkanvalappil SR, El-Sayed MA. Platinum-coated gold 
nanorods: efficient reactive oxygen scavengers that prevent oxidative 
damage toward healthy, untreated cells during plasmonic photothermal 
therapy. ACS Nano. 2017;11(1):579–586.
 51. Wu P, Deng D, Gao J, Cai C. Tube-like gold sphere-attapulgite nano-
composites with a high photothermal conversion ability in the near-
infrared region for enhanced cancer photothermal therapy. ACS Appl 
Mater Interfaces. 2016;8(16):10243–10252.
 52. Feng J, Chen L, Xia Y, et al. Bioconjugation of gold nanobipyramids 
for SERS detection and targeted photothermal therapy in breast cancer. 
ACS Biomater Sci Eng. 2017;3(4):608–618.
 53. Niidome T, Yamagata M, Okamoto Y, et al. PEG-modified gold nano-
rods with a stealth character for in vivo applications. J Control Release. 
2006;114(3):343–347.
 54. Ma Y, Chechik V. Aging of gold nanoparticles: ligand exchange with 
disulfides. Langmuir. 2011;27(23):14432–14437.
 55. Wang Z, Lee JH, Lu Y. Label-free colorimetric detection of lead 
ions with a nanomolar detection limit and tunable dynamic range by 
using gold nanoparticles and DNAzyme. Adv Mater. 2008;20(17): 
3263–3267.
 56. Laurent S, Mahmoudi M. Superparamagnetic iron oxide nanoparticles: 
promises for diagnosis and treatment of cancer. Int J Mol Epidemiol 
Genet. 2011;2(4):367–390.
 57. Maier-Hauff K, Ulrich F, Nestler D, et al. Efficacy and safety of 
intratumoral thermotherapy using magnetic iron-oxide nanoparticles 
combined with external beam radiotherapy on patients with recurrent 
glioblastoma multiforme. J Neurooncol. 2011;103(2):317–324.
 58. Anselmo AC, Mitragotri S. A review of clinical translation of inorganic 
nanoparticles. AAPS J. 2015;17(5):1041–1054.
 59. Lartigue L, Alloyeau D, Kolosnjaj-Tabi J, et al. Biodegradation of 
iron oxide nanocubes: high-resolution in situ monitoring. ACS Nano. 
2013;7(5):3939–3952.
 60. Lee J-H, Jang J, Choi J, et al. Exchange-coupled magnetic nanoparticles 
for efficient heat induction. Nat Nanotechnol. 2011;6(7):418–422.
 61. Yang HW, Hua MY, Liu HL, et al. Self-protecting core-shell magnetic 
nanoparticles for targeted, traceable, long half-life delivery of BCNU 
to gliomas. Biomaterials. 2011;32(27):6523–6532.
 62. Sohail A, Ahmad Z, Bég OA, Arshad S, Sherin L. A review on hyper-
thermia via nanoparticle-mediated therapy. Bull Cancer. 2017;104(5): 
452–461.
 63. Rosensweig RE. Heating magnetic fluid with alternating magnetic field. 
J Magn Magn Mater. 2002;252(1–3 SPEC. ISS.):370–374.
 64. Chu M, Shao Y, Peng J, et al. Near-infrared laser light mediated can-
cer therapy by photothermal effect of Fe3O4magnetic nanoparticles. 
Biomaterials. 2013;34(16):4078–4088.
 65. Shen S, Wang S, Zheng R, et al. Magnetic nanoparticle clusters for 
photothermal therapy with near-infrared irradiation. Biomaterials. 
2015;39:67–74.
 66. Chen H, Burnett J, Zhang F, Zhang J, Paholak H, Sun D. Highly crystal-
lized iron oxide nanoparticles as effective and biodegradable mediators 
for photothermal cancer therapy. J Mater Chem B. 2014;2(7):757–765.
 67. Zhou Z, Sun Y, Shen J, et al. Iron/iron oxide core/shell nanoparticles 
for magnetic targeting MRI and near-infrared photothermal therapy. 
Biomaterials. 2014;35(26):7470–7478.
 68. Chen CL, Kuo LR, Lee SY, et al. Photothermal cancer therapy via 
femtosecond-laser-excited FePt nanoparticles. Biomaterials. 2013; 
34(4):1128–1134.
 69. Espinosa A, Di Corato R, Kolosnjaj-Tabi J, Flaud P, Pellegrino T, 
Wilhelm C. Duality of iron oxide nanoparticles in cancer therapy: 
amplification of heating efficiency by magnetic hyperthermia and 
photothermal bimodal treatment. ACS Nano. 2016;10(2):2436–2446.
 70. Wang J, Qiu J. A review of organic nanomaterials in photothermal 
cancer therapy. Cancer Res Front. 2016;2(1):67–84.
 71. Yang K, Xu H, Cheng L, Sun C, Wang J, Liu Z. In vitro and in vivo 
near-infrared photothermal therapy of cancer using polypyrrole organic 
nanoparticles. Adv Mater. 2012;24(41):5586–5592.
 72. Robinson JT, Tabakman SM, Liang Y, et al. Ultrasmall reduced 
graphene oxide with high near-infrared absorbance for photothermal 
therapy. J Am Chem Soc. 2011;133(17):6825–6831.
 73. Liang C, Diao S, Wang C, et al. Tumor metastasis inhibition by imaging-
guided photothermal therapy with single-walled carbon nanotubes. 
Adv Mater. 2014;26(32):5646–5652.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
86
.3
6.
66
.1
29
 o
n 
18
-M
ay
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2018:13 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2905
Functional nanostructures as cancer photothermal therapy
 74. Hashida Y, Tanaka H, Zhou S, et al. Photothermal ablation of tumor cells 
using a single-walled carbon nanotube-peptide composite. J Control 
Release. 2014;173(1):58–66.
 75. Jin Y, Wang J, Ke H, Wang S, Dai Z. Graphene oxide modified 
PLA microcapsules containing gold nanoparticles for ultrasonic/CT 
bimodal imaging guided photothermal tumor therapy. Biomaterials. 
2013;34(20):4794–4802.
 76. Chen YW, Chen PJ, Hu SH, Chen IW, Chen SY. NIR-triggered syn-
ergic photo-chemothermal therapy delivered by reduced graphene 
oxide/carbon/mesoporous silica nanocookies. Adv Funct Mater. 2014; 
24(4):451–459.
 77. Gonçalves G. Graphene-Based Materials in Health and Environment. 
Vila GGPMM, editor. New York: Springer; 2016.
 78. Bussy C, Ali-Boucetta H, Kostarelos K. Safety considerations for 
graphene: lessons learnt from carbon nanotubes. Acc Chem Res. 2013; 
46(3):692–701.
 79. Kostarelos K, Novoselov KS. Exploring the interface of graphene and 
biology. Science. 2014;344(6181):261–263.
 80. Savchuk OA, Carvajal JJ, Massons J, Aguiló M, Díaz F. Determina-
tion of photothermal conversion efficiency of graphene and graphene 
oxide through an integrating sphere method. Carbon. 2016;103: 
134–141.
 81. Yang K, Hu L, Ma X, et al. Multimodal imaging guided photothermal 
therapy using functionalized graphene nanosheets anchored with mag-
netic nanoparticles. Adv Mater. 2012;24(14):1868–1872.
 82. Zhang H, Wu H, Wang J, et al. Graphene oxide-BaGdF5 nanocom-
posites for multi-modal imaging and photothermal therapy. Biomateri-
als. 2015;42:66–77.
 83. Chen L, Zhong X, Yi X, et al. Radionuclide 131I labeled reduced graphene 
oxide for nuclear imaging guided combined radio- and photothermal 
therapy of cancer. Biomaterials. 2015;66:21–28.
 84. Gong H, Dong Z, Liu Y, et al. Engineering of multifunctional nano-micelles 
for combined photothermal and photodynamic therapy under the guidance 
of multimodal imaging. Adv Funct Mater. 2014;24:6492–6502.
 85. Jian W, Yu T, Chen C, et al. Indocyanine green-encapsulated hybrid 
polymeric nanomicelles for photothermal cancer therapy. Langmuir. 
2015;31:6202–6210.
 86. Kumar P, Srivastava R. IR 820 dye encapsulated in polycaprolactone 
glycol chitosan: Poloxamer blend nanoparticles for photo immuno-
therapy for breast cancer. Mater Sci Eng C. 2015;57:321–327.
 87. Jin CS, Lovell JF, Chen J, Zheng G. Ablation of hypoxic tumors with 
not photodynamic, therapy using a nanostructured porphyrin assembly. 
ACS Nano. 2013;7(3):2541–2550.
 88. Cheng L, Yang K, Chen Q, Liu Z. Organic stealth nanoparticles for 
highly effective in vivo near-infrared photothermal therapy of cancer. 
ACS Nano. 2012;6(6):5605–5613.
 89. Chen M, Fang X, Tang S, Zheng N. Polypyrrole nanoparticles for 
high-performance in vivo near-infrared photothermal cancer therapy. 
Chem Commun. 2012;48(71):8934.
 90. Zha Z, Wang J, Qu E, et al. Polypyrrole hollow microspheres as echo-
genic photothermal agent for ultrasound imaging guided tumor ablation. 
Sci Rep. 2013;3:1–8.
 91. Liang X, Li Y, Li X, et al. PEGylated polypyrrole nanoparticles 
conjugating gadolinium chelates for dual-modal MRI/photoacoustic 
imaging guided photothermal therapy of cancer. Adv Funct Mater. 
2015;25:1451–1462.
 92. Yu H, Chen M, Rice PM, Wang SX, White RL, Sun S. Dumbbell-like 
bifunctional Au−Fe3O4 nanoparticles. Nano Lett. 2005;5(2):379–382.
 93. Mezni A, Balti I, Mlayah A, et al. Hybrid Au-Fe3O4 nanoparticles: 
Plasmonic, surface enhanced Raman scattering, and phase transition 
properties. J Phys Chem C. 2013;117(31):16166–16174.
 94. Brullot W, Valev VK, Verbiest T. Magnetic-plasmonic nanoparticles 
for the life sciences: calculated optical properties of hybrid structures. 
Nanomedicine. 2012;8(5):559–568.
 95. Chaffin EA, Bhana S, O’Connor RT, Huang X, Wang Y. Impact of 
core dielectric properties on the localized surface plasmonic spectra 
of gold-coated magnetic core-shell nanoparticles. J Phys Chem B. 
2014;118(49):14076–14084.
 96. Li Q, Zhang W, Zhao D, Qiu M. Photothermal enhancement in core-
shell structured plasmonic nanoparticles. Plasmonics. 2014;9(3): 
623–630.
 97. Encina ER, Coronado EA. Size optimization of iron oxide@noble 
metal core-shell nanohybrids for photothermal applications. J Phys 
Chem C. 2016;120(10):5630–5639.
 98. Ahmed OS, Mohamed MB, Zekri ARN, Imam H, Khaled HM, 
Abdel-kader MH. Synthesis of the newly developed core-shell Au/
Fe3O4 magnato-plasmonic nanocomposite in cancer cells. Life Sci J. 
2014;11(10):182–187.
 99. Niu C, Xu Y, An S, et al. Near-infrared induced phase-shifted ICG/
Fe3O4 loaded PLGA nanoparticles for photothermal tumor ablation. 
Sci Rep. 2017;7(1):1–10.
 100. Meng L, Xia W, Liu L, Niu L, Lu Q. Golden single-walled carbon nan-
otubes prepared using double layer polysaccharides bridge for photo-
thermal therapy. ACS Appl Mater Interfaces. 2014;6(7):4989–4996.
 101. Gao S, Zhang L, Wang G, et al. Hybrid graphene/Au activatable 
theranostic agent for multimodalities imaging guided enhanced pho-
tothermal therapy. Biomaterials. 2016;79:36–45.
 102. Darabdhara G, Das MR, Turcheniuk V. Reduced graphene oxide 
nanosheets decorated with AuPd bimetallic nanoparticles: a multi-
functional material for photothermal therapy of cancer cells. J Mater 
Chem B. 2015;3(42):8366–8374.
 103. Akhavan O, Meidanchi A, Khoei S. Zinc ferrite spinel-graphene in 
magneto-photothermal therapy of cancer. J Mater Chem B. 2014;2(21): 
3306–3314.
 104. Criado A, Prato M. Recent advances of graphene-based hybrids with 
magnetic nanoparticles for biomedical applications. Curr Med Chem. 
2017;24(5):529–536.
 105. Du C, Wang A, Fei J, Zhao J, Li J. Polypyrrole-stabilized gold nanorods 
with enhanced photothermal effect towards two-photon photothermal 
therapy. J Mater Chem B. 2015;3(22):4539–4545.
 106. Feng W, Zhou X, Nie W, et al. Au/polypyrrole @ Fe3O4 nanocompos-
ites for MR/CT dual-modal imaging guided-photothermal therapy: an 
in vitro study. ACS Appl Mater Interfaces. 2015;7(7):4354–4367.
 107. Chen Y, Wang L, Shi J. Two-dimensional non-carbonaceous materials- 
enabled efficient photothermal cancer therapy. Nano Today. 2016; 
11(3):292–308.
 108. Naguib M, Kurtoglu M, Presser V, et al. Two-dimensional nanocrys-
tals produced by exfoliation of Ti 3AlC 2. Adv Mater. 2011;23(37): 
4248–4253.
 109. Karlsson LH, Birch J, Halim J, Barsoum MW, Persson PO. Atomi-
cally resolved structural and chemical investigation of single MXene 
sheets. Nano Lett. 2015;15(8):4955–4960.
 110. Lin H, Wang X, Yu L, Chen Y, Shi J. Two-dimensional ultrathin 
MXene ceramic nanosheets for photothermal conversion. Nano Lett. 
2017;17(1):384–391.
 111. Cheng L, Liu J, Gu X, et al. PEGylated WS2 nanosheets as a multifunc-
tional theranostic agent for in vivo dual-modal CT/photoacoustic imaging 
guided photothermal therapy. Adv Mater. 2014;26(12):1886–1893.
 112. Zhu Z, Zou Y, Hu W, et al. Near-infrared plasmonic 2D semimetals for 
applications in communication and biology. Adv Funct Mater. 2016; 
26(11):1793–1802.
 113. Dai C, Lin H, Xu G, Liu Z, Wu R, Chen Y. Biocompatible 2D titanium 
carbide (MXenes) composite nanosheets for pH-responsive MRI-
guided tumor hyperthermia. Chem Mater. 2017;29(20):8637–8652.
 114. Li W, Rong P, Yang K, Huang P, Sun K, Chen X. Semimetal nanoma-
terials of antimony as highly efficient agent for photoacoustic imaging 
and photothermal therapy. Biomaterials. 2015;45:18–26.
 115. Yu J, Ju Y, Zhao L, et al. Multistimuli-regulated photochemothermal 
cancer therapy remotely controlled via Fe5C2nanoparticles. ACS 
Nano. 2016;10(1):159–169.
 116. Zhou Z, Kong B, Yu C, et al. Tungsten oxide nanorods: An efficient 
nanoplatform for tumor CT imaging and photothermal therapy. 
Sci Rep. 2014;4:1–10.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
86
.3
6.
66
.1
29
 o
n 
18
-M
ay
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
 MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2018:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
2906
Hussein et al
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
86
.3
6.
66
.1
29
 o
n 
18
-M
ay
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
